p21
Waf1/Cip1/Sdi1 is an important mediator of growth arrest and senescence in mammalian cells (reviewed in Gartel and Tyner, 1998) . Because of its pivotal role in p53-regulated growth arrest, p21 is usually regarded as a tumor suppressor. Nevertheless, p21 mutations in human cancer are rare (Hall and Peters, 1996) , and p21 knockout mice develop normally and do not show an increased rate of tumorigenesis (Deng et al., 1995) . Increased p21 expression leads to cell growth arrest (Noda et al., 1994) , which occurs in both G1 and G2 (Niculescu et al., 1998) and is accompanied by the development of morphologic and phenotypic markers of senescence in some or all cells (Vogt et al., 1998; McConnell et al., 1998; Bates et al., 1998; Fang et al., 1999; Chang et al., 1999a) . p21-mediated growth arrest stems from its ability to inhibit cyclin-dependent kinase (CDK) complexes that regulate transitions between dierent phases of the cell cycle (Gartel and Tyner, 1998) . Consequences of CDK inhibition include dephosphorylation of Rb and downregulation of a large group of E2F-dependent genes that are involved in DNA replication and cell cycle progression (Nevins, 1998) . The latter eect is usually attributed to the sequestration of E2F by dephosphorylated Rb, but p21 was also shown to inhibit E2F in Rb-negative cells (Dimri et al., 1996) . p21 induction, mediated by p53-dependent and p53-independent factors, has been associated with both transient and permanent forms of growth arrest in mammalian cells. p21-mediated transient growth arrest prevents the entry of damaged cells into mitosis and the resulting mitotic catastrophe (Bunz et al., 1998) . On the other hand, transient p21 induction also occurs at the onset of permanent growth arrest (a.k.a. accelerated senescence), which is induced in normal ®broblasts (DiLeonardo et al., 1994; Robles and Adami, 1998) and in tumor cells (Chang et al., 1999b) by DNA damage or introduction of oncogenic RAS (Serrano et al., 1997) . p21 is also induced at the onset of terminal growth arrest during replicative senescence of aging ®broblasts (Noda et al., 1994) . A transient surge of p21 expression in both replicative and accelerated senescence is followed by the induction of another CDK inhibitor, p16
INK4A
, which remains at a high level and may be responsible for the maintenance of growth arrest in senescent cells after the decay of p21 (Alcorta et al., 1996; Robles and Adami, 1998; Stein et al., 1999) .
To investigate the cellular consequences of transient p21 induction, we have previously developed the p21-9 cell line, a derivative of p16-de®cient HT1080 human ®brosarcoma cells, where p21 expression can be turned on or o using a physiologically neutral agent isopropyl-b-thio-galactosidase (IPTG) (Chang et al., 1999a) . IPTG treatment of p21-9 cells leads to 15 ± 20-fold increase in p21 expression, dephosphorylation of Rb, and complete cessation of DNA replication and mitosis within 15 h after the addition of IPTG. Similar numbers of IPTG-treated p21-9 cells (42 ± 43% each) become arrested in G1 and G2, and about 15% of the cells are arrested with S phase DNA content (data not shown and Figure 2d , 0 h time point).
We have previously found that all IPTG-treated p21-9 cells develop morphological markers of senescence (Chang et al., 1999a) . We now asked if this senescent phenotype is associated with a restricted proliferative capacity after release from p21 induction. p21-9 cells were treated with three dierent doses of IPTG (0.5, 5 and 50 mM) that induce, respectively, no measurable increase over the basal p21 level, half-maximal or maximal increase (Chang et al., 1999a) . As shown in Figure 1a , 0.5 mM IPTG did not inhibit colony formation, while continuous exposures to 5 mM or 50 mM IPTG reduced the clonogenicity of p21-9 cells by 80 and 100%, respectively. When IPTG was removed after 12 or 24 h, cells treated with 5 mM IPTG showed essentially undiminished colony formation, but the clonogenicity of 50 mM IPTG-treated cells decreased by 58 ± 63%. After 3 ± 5 days of IPTG treatment, colony formation decreased by 55 ± 58% in 5 mM IPTG-treated cells and by 95 ± 99% in cells treated with 50 mM IPTG. Thus, the ability of cells to recover after p21 decay was inversely correlated with the induced levels of p21 and the duration of p21 induction. A correlation between the duration of p21 induction and the failure to recover was also observed by Fang et al. (1999) in EJ carcinoma cells.
We have investigated the causes of the loss of clonogenicity after release from prolonged treatment with 50 mM IPTG. Plates treated with 50 mM IPTG for 3 or more days contained numerous single cells and small cell clusters that failed to develop into colonies after removal of IPTG, indicating a restriction in cellular proliferative capacity. In addition, many cells detached from the plate during the ®rst 2 days after release from IPTG; the number of such cells was much higher when cells were released after 3 days than after 1 day of IPTG treatment ( Figure 1b) . Most of these¯oating cells were dead, as indicated by trypan blue staining and 100 ± 1000-fold decrease in clonogenicity. The failure to recover after release from p21 was not due to incomplete shuto of p21 expression, since cellular p21 reverted to its basal level within 20 ± 24 h after the removal of IPTG (Figure 1c) . Resumption of DNA replication in cells treated with IPTG for either 1 of 5 days was ®rst detected 20 h ( Figure 1d ) and resumption of mitosis 30 h (Figure 1e ) after release. The percentages of cells entering the S or M phases were higher among cells that were treated with IPTG for 1 day than for 5 days (Figure 1d ,e), but this dierence appeared too small to account for the corresponding dierence in clonogenic recovery ( Figure 1a) .
For further analysis, we have examined the DNA content of growth-retarded and dead cells that arise after release from IPTG. Growth-retarded cells were isolated using a¯uorescence-activated cell sorter (FACS) on the basis of increased retention of a membrane-labeling¯uorophore PKH2, as previously described (Chang et al., 1999b) . Untreated p21-9 cells and cells treated with 50 mM IPTG for 5 days were labeled with PKH2, plated in IPTG-free medium, and their PKH2¯uorescence was analysed on consecutive days. As shown in Figure 2a , IPTG-treated cells started dividing later than the control cells and developed a heterogeneous PKH2 pro®le, with an emerging peak of proliferating cells and a shoulder of growth-retarded cells with high PKH2¯uorescence. The growthretarded cells also showed elevated side scatter (SS; Figure 2 (a) Changes in PKH2¯uorescence pro®les of untreated cells (left) and cells treated for 5 days with 50 mM IPTG, labeled with PKH2 and released in IPTG-free media. Analysis was carried out using Becton Dickinson FACSort as described (Chang et al., 1999b) . (b) FACS pro®les of DNA content (determined after PI staining as described by Jordan et al., 1996) not shown), which is characteristic for senescent cells (Chang et al., 1999b ) cell populations were separated by FACS 6 days after release from IPTG, and their DNA content was analysed by PI staining. The growth-retarded fraction diered from the proliferating cells in having a higher G2/M fraction and a large number of cells with greater than 4C DNA content (Figure 2b) . The polyploid nature of the latter cells was con®rmed by¯uorescence in situ hybridization (FISH) of interphase nuclei with probes speci®c for chromosomes 18 and 21 (data not shown). High polyploid and G2/M fractions were also observed among¯oating dead cells collected after release from IPTG ( Figure 2c) ; microscopic analysis indicated that many of these non-viable cells were in mitosis.
The development of polyploidy after p21 overexpression has been recently described in several tumor-derived cell lines (Niculescu et al., 1998; Bates et al., 1998) , and p21 has been implicated in polyploidization associated with megakaryocytic dierentiation (Kikuchi et al., 1997) . To investigate the origin of polyploid cells that we have found to be enriched in the growth-retarded and dead cell populations, we analysed the time course of changes in DNA content of the p21-9 cell population after release from IPTG. The number of polyploid cells greatly increased 24 ± 28 h after release (Figure 2d) , concurrently with the resumption of DNA synthesis (Figure 1d ). This result indicated that many of the released cells were undergoing endoreduplication, an unscheduled round of DNA replication. The time course and magnitude of endoreduplication were very similar, however, between cells released after 1 day (Figure 2d ) or after 3 ± 5 days of IPTG inhibition (not shown).
A major dierence between cells that were treated with 50 mM IPTG for 1 day or for 5 days emerged, however, when we examined the morphology of attached mitotic cells arising 1 ± 2 days after release (Figure 3) . While an overwhelming majority of mitotic ®gures in untreated cells appeared morphologically normal (Figure 3, left) , most of the mitotic ®gures in cells released after IPTG treatment showed numerous abnormalities, including multipolar anaphases, uneven chromosome distribution and prophase arrest (Figure  3, right) . The percentages of normal mitoses in 1-day and 5-day IPTG treated cells were 45 and 2%, respectively, which is close to the corresponding values for clonogenic recovery (38 and 1%). These results suggest that abnormal mitosis is primarily responsible for the loss of clonogenicity after release from p21.
The mitotic abnormalities of the type shown in Figure 3 have been previously found to result from mutation or inhibition of proteins that control proper chromosome alignment and segregation (Li and Benezra, 1996; Glover et al., 1998; Chan et al., 1999) . As reported elsewhere (Chang et al., 2000) , we have carried out cDNA array analysis of p21-mediated changes in gene expression in p21-9 cells and found that p21 induction results in the inhibition of multiple genes associated with cell division. Figure 4a shows the results of RT ± PCR assays demonstrating that IPTG treatment drastically decreases the RNA levels of a group of genes that control dierent stages of mitosis. These include CDC2 and cyclin B1 that form the mitosis-initiating complex (Kishimoto and Okumura, 1997), polo-like kinase (PLK1) that plays a role in the onset of mitosis, mitotic checkpoint control and cytokinesis (Glover et al., 1998) , CDC2-interacting protein CKsHs1, a target of mitotic checkpoint control (Hixon et al., 1998) , mitotic centromere-associated kinesin (MCAK; Kuriyama et al., 1995) , a centrosome-associated kinase AIK1 involved in spindle formation (Kimura et al., 1997) , centromere proteins CENP-A and CENP-F (Liao et al., 1995; Kalitsis et al., 1998) , as well as MAD2 and BUBR1 genes that play a central role in the spindle checkpoint control (Li and Benezra, 1996; Chan et al., 1999) , CHL1 helicase (a homolog of a yeast protein that plays a role in proper chromosome distribution during mitosis; Gerring et al., 1990), and genes for three proteins involved in cytokinesis, Prc1, Aim1 and citron kinase (Jiang et al., 1998; Terada et al., 1998; Madaule et al., 1998) . IPTG-induced decay of the corresponding proteins has also been con®rmed for several of these genes by immunoblotting (Figure 4b ). The results in Figure 4 suggest an explanation for mitotic abnormalities that occur after release from p21. If high p21 levels are maintained long enough to deplete the cellular pool of mitosis control proteins, mitosis-initiating proteins would have to be regenerated after the shuto of p21 before the cell can enter mitosis. However, if the proteins involved in thè quality control' of mitosis are not re-synthesized to a sucient level at the same time, abnormal mitosis would ensue. The immunoblotting analysis of the time course of decay and resynthesis of mitosis control proteins (Figure 4b ) supports this interpretation. None of the tested mitosis-control proteins show detectable regeneration 24 h after release from IPTG, in agreement with the lack of mitotic cells at this time point (Figure 1e) . By the time of resumed mitosis (36 h after release), the pools of Cdc2 and Plk1, which are required for the initiation of mitosis, are regenerated to levels comparable to untreated cells (Figure 4b ). In contrast, Mad2, the function of which is to prevent anaphase unless chromosomes are properly attached to the mitotic spindle, is resynthesized much less eciently (Figure 4b) . Furthermore, Mad2 protein is still detectable after 1 day of IPTG treatment but not after 3 or more days (Figure 4b ), which agrees with a lower frequency of abnormal mitoses in cells that are released after 1 day of p21 induction.
Polyploidization that occurs after release from p21 can also be attributed to the inhibition of protein expression by p21. In particular, p21-induced decay of Cdc2 could interfere with control mechanisms that prevent illegitimate DNA replication by acting at the replication licensing factor (RLF). These mechanisms include Cdc2-mediated phosphorylation events that inactivate the MCM protein component of RLF (Hendrickson et al., 1996) and activate a RLF inhibitor (Mahbubani et al., 1997) . It has also been suggested that endoreduplication may result from the abrogation of mitotic checkpoint control (Hixon et al., 1998) , which could be due to p21-mediated depletion of checkpoint control proteins. Furthermore, polyploid cells could arise from a failure of cytokinesis that can be triggered by a lack of cytokinesis-associated proteins inhibited by p21, such as Prc1, Aim1 and citron kinase.
Karyotypic changes have been frequently observed in senescent cells in vitro and in vivo (reviewed in Schimke et al., 1986) . We suggest that such changes may be due at least in part to genetic destabilization that results from accidental re-entry into the cell cycle of cells that underwent prolonged p21 induction in the course of senescence. Transient p21 induction triggers growth arrest of senescent cells, whereas another CDK inhibitor, p16, appears to be responsible for maintaining this growth arrest after the decay of p21 (Alcorta et al., 1996; Stein et al., 1999) . p16 (in striking contrast to p21) is frequently mutated in human tumors (Hall and Peters, 1996) , including HT1080 ®brosarcoma used in the present study. We hypothesize that the primary carcinogenic eect of p16 mutations is enabling the cells that experienced prolonged p21 induction to reenter the cell cycle. Unlike p16, p21 would act more as an oncogene than as a tumor suppressor in this process, which can explain the rarity of p21-inactivating mutations in cancer.
As previously suggested by Niculescu et al. (1998) , p21 induction may also result in genetic destabilization of tumor cells exposed to radiation therapy or chemotherapy, leading to the emergence of more malignant or treatment-resistant tumor variants. Transient exposure of transformed cell lines to cell cycle perturbing agents (many of which are known to induce p21) leads to increased DNA ploidy, gene ampli®cation and other karyotypic abnormalities (Schimke et al., 1991) . We have previously shown that treatment of tumor cells with dierent chemotherapeutic drugs induces a senescent phenotype, and that this phenotype, which largely depends on the p21 function, is also associated with increased DNA ploidy (Chang et al., 1999a,b) . Thus, re-entry into cell cycle after high-level Figure 4 (a) Eects of p21 induction on mRNA levels of mitosis-associated genes. RT ± PCR was carried out as described (Noonan et al., 1990) , using b2-microglobulin (b2-M) as a normalization control. Sequences of RT ± PCR primers will be provided upon request. C, control untreated p21-9 cells; I, cells treated for 3 days with 50 mM IPTG. (b) Immunoblotting analysis of the time course of changes in the expression of mitosisassociated proteins upon IPTG addition and release. Protein concentrations in all samples were equalized after measurement with BioRad protein assay kit. Immunoblotting was carried out by standard procedures using mouse monoclonal antibodies against Cdc2 (Santa Cruz) and Plk1 (Zymed) and rabbit polyclonal antibodies against Mad2 (BabCo) and Prc1 (a gift of Drs W Jiang and T Hunter). HRP-conjugated goat anti-mouse and goat anti-rabbit IgG (Santa Cruz) were used as secondary antibodies, and the signal was detected by chemiluminescence using LumiGlo (KPL). A non-speci®c 110 kDa band that crossreacts with the Plk1 antibody (ns) is shown as a normalization control induction of p21 may serve as a major cause of genetic destabilization that contributes to carcinogenesis and tumor progression.
